المؤلفون: Elias Rojas Pantoja, Elizabeth Valero-Pacheco, Margarito Páez-Rodríguez, Oscar Méndez

المصدر: Revista Biológico Agropecuaria Tuxpan, Vol 11, Iss 1 (2023)

مصطلحات موضوعية: Digenea, Golfo de México, Larvas, Nematoda, Peces, Veterinary medicine, SF600-1100, Agriculture

وصف الملف: electronic resource

Relation: https://revistabioagro.mx/index.php/revista/article/view/461; https://doaj.org/toc/2007-6940

URL الوصول: https://doaj.org/article/fb96c80b8e5b466eb12b646442c04eb0

المؤلفون: Chuharski, Jake, Collins, Elias Rojas, Meringolo, Mark

مصطلحات موضوعية: Computer Science - Artificial Intelligence

URL الوصول: http://arxiv.org/abs/2412.16177

المؤلفون: Collins, Elias Rojas, Köcher, Chris, Zetzsche, Georg

مصطلحات موضوعية: Computer Science - Formal Languages and Automata Theory

URL الوصول: http://arxiv.org/abs/2410.00548

المؤلفون: Dino Manco Jaraba, Elias Rojas Martínez, Antonio Rudas Muñoz, Yesica Moscote Daza

المصدر: Ingenierías USBMed, Vol 9, Iss 2, Pp 2-49 (2018)

مصطلحات موضوعية: Clasificación de suelos, Granulometría, Sedimentología, Sedimentos, Suelo, Technology, Engineering (General). Civil engineering (General), TA1-2040

وصف الملف: electronic resource

Relation: https://revistas.usb.edu.co/index.php/IngUSBmed/article/view/3498/2884; https://doaj.org/toc/2027-5846

URL الوصول: https://doaj.org/article/c1f8d674a65c43f38de94a651cd486c7

المؤلفون: María Isabel Acosta Colmán, Gabriela Avila Pedretti, Alicia Maria Aquino Valdovinos, Elias Rojas, Jhonatan Losanto, María Eugenia Acosta, Marcia Melo, María Teresa Martinez, Margarita Duarte

المصدر: Memorias del Instituto de Investigaciones en Ciencias de la Salud, Vol 15, Iss 1 (2017)

مصطلحات موضوعية: lupus eritematoso sistémico, factores de riesgo cardiovascular, Medicine (General), R5-920

وصف الملف: electronic resource

Relation: https://revistascientificas.una.py/index.php/RIIC/article/view/1895; https://doaj.org/toc/1817-4620; https://doaj.org/toc/1812-9528

URL الوصول: https://doaj.org/article/d4c511648a7445ffa461c4cd5643efee

المؤلفون: Michel, Jesse, Mu, Kevin, Yang, Xuanda, Bangaru, Sai Praveen, Collins, Elias Rojas, Bernstein, Gilbert, Ragan-Kelley, Jonathan, Carbin, Michael, Li, Tzu-Mao

المصدر: Association for Computing Machinery

وصف الملف: application/pdf

Relation: Proceedings of the ACM on Programming Languages; https://hdl.handle.net/1721.1/154393; Michel, Jesse, Mu, Kevin, Yang, Xuanda, Bangaru, Sai Praveen, Collins, Elias Rojas et al. 2024. "Distributions for Compositionally Differentiating Parametric Discontinuities." Proceedings of the ACM on Programming Languages, 8 (OOPSLA1).; PUBLISHER_CC

الاتاحة: https://hdl.handle.net/1721.1/154393

المؤلفون: Marcos Aurelio Vázquez, Alexis Pineda, Vannia Valinotti, Astrid Paats, Rodrigo Acosta, Elías Rojas

المصدر: Paraguayan Journal of Rheumatology; Vol. 7 Núm. 1 (2021): Enero-Junio; 2-6 ; Revista Paraguaya de Reumatología; Vol. 7 Núm. 1 (2021): Enero-Junio; 2-6 ; 2413-4341 ; 2413-709X

وصف الملف: application/pdf

Relation: http://www.revista.spr.org.py/index.php/spr/article/view/133/225; Kvarnström, M., Ottosson, V., Nordmark, B., Wahren-Herlenius, M. Incident cases of primary Sjögren syndrome during a 5-year period in Stockholm County: a descriptive study of the patients and their characteristics. Scandinavian journal of rheumatology. 2015; 44(2), 135–142. https://doi.org/10.3109/03009742.2014. 931457; Weng, M. Y., Huang, Y. T., Liu, M. F., Lu, T. H. (2011). Incidence and mortality of treated primary Sjogren: syndrome in Taiwan: a popula- tion-based study. The Journal of rheumatology. 2011; 38(4), 706– 708.; Maldini, C., Seror, R., Fain, O., Dhote, R., Amoura, Z., De Bandt, M. et al.; Epidemiology of primary Sjögren syndrome in a French multiracial/multiethnic area. Arthritis care & research. 2014; 66(3), 454–463.; Nakamura H, Takahashi Y, Yamamoto-Fukuda T. Direct infection of primary salivary gland epithelial cells by human T lymphotropic virus type I in patients with Sjögren syndrome. Arthritis Rheumatol. 2015;67(4):1096-1106.; Reveille, J. D., Wilson, R. W., Provost, T. T., Bias, W. B., Arnett, F. C. Primary Sjögren syndrome and other autoimmune diseases in families. Prevalence and immunogenetic studies in six kindreds. Annals of internal medicine. 1984;101(6), 748–756.; Quartuccio, L., Isola, M., Corazza, L., Ramos-Casals, M., Retamozo, S., Ragab, G. M. et al. Validation of the classification criteria for cryoglobulinaemic vasculitis. Rheumatology (Oxford, England). 2014; 53(12), 2209–2213.; Retamozo, S., Gheitasi, H., Quartuccio, L., Kostov, B., Corazza, L., Bové, A., Sisó-Almirall, A.,et al. Cryoglobulinaemic vasculitis at diagnosis predicts mortality in primary Sjögren syndrome: analysis of 515 patients. Rheumatology (Oxford, England). 2016; 55(8), 1443–1451.; Ramos-Casals, M., Solans, R., Rosas, J., Camps, M. T., Gil, A., Del Pino-Montes, J., et al. Primary Sjögren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine. 2008: 87(4), 210–219.; Ramos-Casals, M., Tzioufas, A. G., Font, J. Primary Sjögren syn- drome: new clinical and therapeutic concepts.Annals of the rheumatic diseases. 2005; 64(3), 347–354.; Kyriakidis, N. C., Kapsogeorgou, E. K., Gourzi, V. C., Konsta, O. D.,Baltatzis, G. E., Tzioufas, A. G. Toll-like receptor 3 stimulation promotes Ro52/TRIM21 synthesis and nuclear redistribution in salivary gland epithelial cells, partially via type I interferon pathway. Clinical and experimental immunology. 2014; 178(3), 548– 560.; Hall, J. C., Casciola-Rosen, L., Berger, A. E., Kapsogeorgou, E. K., Cheadle, C., Tzioufas, A. G.,et al. Precise probes of type II inter- feron activity define the origin of interferon signatures in target tissues in rheumatic diseases. Proceedings of the National Academy of Sciences of the United States of America. 2012; 109 (43), 17609–17614.; Nocturne, G., Mariette, X. Sjögren Syndrome-associated lympho- mas: an update on pathogenesis and management. British journal of haematology. 2015; 168(3), 317–327.; Nocturne, G., Boudaoud, S., Miceli-Richard, C., Viengchareun, S., Lazure, T., Nititham, J., et al. Germline and somatic genetic varia- tions of TNFAIP3 in lymphoma complicating primary Sjogren syndrome. 2013; Blood, 122(25), 4068–4076.; Fabini, G., Rutjes, S. A., Zimmermann, C., Pruijn, G. J., Steiner, G. Analysis of the molecular composition of Ro ribo nucleoprotein complexes. Identification of novel Y RNA-binding proteins. European journal of biochemistry. 2000; 267(9), 2778–2789.; Mekinian, A., Nicaise-Roland, P., Chollet-Martin, S., Fain, O., & Crestani, B. (2013). Anti-SSA Ro52/Ro60 antibody testing by immunodot could help the diagnosis of Sjogren syndrome in the absence of anti-SSA/SSB antibodies by ELISA. Rheumatology. 2013; 52(12), 2223–2228.; Seror, R., Ravaud, P., Bowman, S. J., Baron, G., Tzioufas, A., Theander, E. EULAR Sjogren syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren syndrome. Annals of the rheumatic diseases. 2010; 69(6), 1103–1109.; Skopouli, F. N., Barbatis, C., Moutsopoulos, H. M. Liver involvement in primary Sjögren syndrome. British journal of rheumatology. 1994; 33(8), 745–748.; Bartoloni, E., Baldini, C., Schillaci, G., Quartuccio, L., Priori, R., Carubbi, F., et al. Cardiovascular disease risk burden in primary Sjögren syndrome: results of a population-based multicentre cohort study. Journal of internal medicine. 2015; 278(2), 185–192.; Lazarus, M. N., & Isenberg, D. A. Development of additional autoimmune diseases in a population of patients with primary Sjögren syndrome. Annals of the rheumatic diseases. 2005; 64(7), 1062–1064.; Saito, T., Fukuda, H., Arisue, M., Matsuda, A., Shindoh, M., Amemiya, et al. Relationship between sialographic findings of parotid glands and histopathologic finding of labial glands in Sjögren syndrome. Relation to clinical and immunologic findings. Oral surgery, oral medicine, and oral pathology. 1991; 72(6), 675–680.; Bowman, S. J., Pillemer, S., Jonsson, R., Asmussen, K., Vitali, C., Manthorpe, R., et al. Contributors to and participants at the work- shop. Revisiting Sjögren syndrome in the new millennium: perspectives on assessment and outcome measures. Report of a workshop held on 23 March 2000 at Oxford, UK. Rheumatology (Oxford, England). 2001; 40(10), 1180–1188.; Seror, R., Gottenberg, J. E., Devauchelle-Pensec, V., Dubost, J. J., Le Guern, V., et al. Assessment of systemic disease activity is complementary to assessment of patients symptoms in primary Sjogren syndrome. Ann Rheum Dis. 2011; 70(Suppl 3), 505.; Theander, E., Vasaitis, L., Baecklund, E., Nordmark, G., Warfvinge, G., Liedholm, R., et al. . Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren syndrome. Annals of the rheumatic diseases. 2011; 70(8), 1363–1368.; http://www.revista.spr.org.py/index.php/spr/article/view/133

الاتاحة: http://www.revista.spr.org.py/index.php/spr/article/view/133
https://doi.org/10.18004/rpr/2021.07.01.2

المؤلفون: Elías Rojas, Sonia Cabrera Villalba

المصدر: Paraguayan Journal of Rheumatology; Vol. 6 Núm. 1 (2020): Enero-Junio; 36-47 ; Revista Paraguaya de Reumatología; Vol. 6 Núm. 1 (2020): Enero-Junio; 36-47 ; 2413-4341 ; 2413-709X

وصف الملف: application/pdf

Relation: http://www.revista.spr.org.py/index.php/spr/article/view/119/213; Rindfleisch JA, Muller D. Diagnosis and management of rheumatoid arthritis. Am Fam Physician. 2005;72(6):1037-47.; Hunt N, Talabi MB. Family Planning and Rheumatoid Arthritis. Current rheumatology reports. 2019;21(5):16.; Conigliaro P, Triggianese P, De Martino E, Chimenti MS, Sunzini F, Viola A, et al. Challenges in the treatment of Rheumatoid Arthritis. Autoimmunity reviews. 2019.; Giles I, Yee C-S, Gordon C. Stratifying management of rheumatic disease for pregnancy and breastfeeding. Nature Reviews Rheumatology. 2019;15(7):391-402.; Wallenius M, Salvesen KA, Daltveit AK, Skomsvoll JF. Secular trends of pregnancies in women with inflammatory connective tissue disease. Acta Obstet Gynecol Scand. 2015;94(11):1195-202.; Wallenius M, Skomsvoll JF, Irgens LM, Salvesen KA, Nordvag BY, Koldingsnes W, et al. Parity in patients with chronic inflammatory arthritides childless at time of diagnosis. Scand J Rheumatol. 2012;41(3):202-7.; Walldorf J, Brunne S, Gittinger FS, Michl P. Family planning in inflammatory bowel disease: childlessness and disease-relatedconcerns among female patients. Eur J Gastroenterol Hepatol. 2018;30(3):310-5.; Brouwer J, Hazes JM, Laven JS, Dolhain RJ. Fertility in women with rheumatoid arthritis: influence of disease activity and medication.Ann Rheum Dis. 2015;74(10):1836-41.; Leroy C, Rigot JM, Leroy M, Decanter C, Mapihan KL, Parent AS, et al. Immunosuppressive drugs and fertility. Orphanet J Rare Dis. 2015;10:136.; Clowse ME, Chakravarty E, Costenbader KH, Chambers C, Michaud. K. Effects of infertility, pregnancy loss, and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res. 2012;64(5):668-74.; Key statistics from the National Survey of Family Growth, (2016).; de Man YA, Dolhain RJ, Geijn FEvd, Willemsen SP, Hazes JM. Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study. Arthritis Rheum. 2008;59(9):1241-8.; Ostensen M, Fuhrer L, Mathieu R, Seitz M, Villiger PM. A prospective study of pregnant patients with rheumatoid arthritis and ankylosing spondylitis using validated clinical instruments. Ann Rheum Dis. 2004;63(10):1212-7.; De Man Y, Bakker-Jonges L, Dufour-Van Den Goorbergh C, Tillemans S, Hooijkaas H, Hazes J, et al. Women with rheumatoid arthritis negative for anti-cyclic citrullinated peptide and rheumatoid factor are more likely to improve during pregnancy, whereas in autoantibody-positive women autoantibody levels are not influenced by pregnancy. Annals of the rheumatic diseases. 2010;69(2):420-3.; Barrett JH, Brennan P, Fiddler M, Silman AJ. Does rheumatoid arthritis remit during pregnancy and relapse postpartum? Results from a nationwide study in the United Kingdom performed prospectively from late pregnancy. Arthritis Rheum. 1999;42(6):1219-27.; Brandt Svd, Zbinden A, Baeten D, Villiger PM, Ostensen M, Forger F. Risk factors for flare and treatment of disease flares during pregnancy in rheumatoid arthritis and axial spondyloarthritis patients. Arthritis Res Ther. 2017;19(1):64.; Kishore S, Mittal V, Majithia V, editors. Obstetric Outcomes in Women with Rheumatoid Arthritis: Results from Nationwide Inpatient Sample Database 2003-2011. Seminars in Arthritis and Rheumatism; 2019: Elsevier.; Remaeus K, Johansson K, Askling J, Stephansson O. Juvenile onset arthritis and pregnancy outcome: a population-based cohort study. Ann Rheum Dis. 2017;76(11):1809-14.; Zrour SH, Boumiza R, Sakly N, Mannai R, Korbaa W, Younes M, et al. The impact of pregnancy on rheumatoid arthritis outcome: the role of maternofetal HLA class II disparity. Joint Bone Spine. 2010;77(1):36-40.; Mahadevan U, Wolf DC, Dubinsky M, Cortot A, Lee SD, Siegel CA, et al. Placental transfer of anti–tumor necrosis factor agents in pregnant patients with inflammatory bowel disease. Clinical Gastroenterology and Hepatology. 2013;11(3):286-92.; Kahn DA, Baltimore. D. Pregnancy induces a fetal antigen-specific maternal T regulatory cell response that contributes to tolerance. Proc Natl Acad Sci U S A 2010;107(20):9299-304.; Corthay A. How do regulatory T cells work? Scand J Immunol. 2009;70(4):326-36.; Forger F, Marcoli N, Gadola S, Moller B, Villiger PM, Ostensen M. Pregnancy induces numerical and functional changes of CD4+CD25 high regulatory T cells in patients with rheumatoid arthritis. Ann Rheum Dis. 2008;67(7):984–90.; Yael A, Dolhain RJ, Hazes JM. Disease activity or remission of rheumatoid arthritis before, during and following pregnancy. Current opinion in rheumatology. 2014;26(3):329-33.; Van den Broek N, Letsky E. Pregnancy and the erythrocyte sedimentation rate. BJOG: An International Journal of Obstetrics & Gynaecology. 2001;108(11):1164-7.; de Man YA, Hazes JM, van de Geijn FE, Krommenhoek C, Dolhain RJ. Measuring disease activity and functionality during pregnancy in patients with rheumatoid arthritis. Arthritis Care & Research: Official Journal of the American College of Rheumatology. 2007;57(5):716-22.; Baffour FI, McKenzie GA, Bekele DI, Glazebrook KN. Sonography of active rheumatoid arthritis during pregnancy: a case report and literature review. Radiology Case Reports. 2018;13(6):1233-7.; Ray JG, Vermeulen MJ, Bharatha A, Montanera WJ, Park AL. Association between MRI exposure during pregnancy and fetal and childhood outcomes. JAMA. 2016;316(9):952-61.; Brown AK, Quinn MA, Karim Z, Conaghan PG, Peterfy CG, Hensor E, et al. Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural rogression. Arthritis Rheum. 2006;54(12):3761-73.; Terslev L, Torp-Pedersen S, Savnik A, Recke Pvd, Qvistgaard E, Danneskiold-Samsoe B, et al. Doppler ultrasound and magnetic resonance imaging of synovial inflammation of the hand in rheumatoid arthritis: a comparative study. Arthritis Rheum. 2003;48(9):2434–41.; D’Agostino MA, Terslev L, Aegerter P, Backhaus M, Balint P, Bruyn GA, et al. Scoring ultrasound synovitis in rheumatoid arthritis: a EULAR-OMERACT ultrasound taskforce-Part 1: definition and development of a standardised, consensus-based scoring system. RMD Open. 2017;3(1):e000428.; Wakefield RJ, Balint PV, Szkudlarek M, Filippucci E, Backhaus M, D’Agostino MA, et al. Musculoskeletal ultrasound including definitions for ultrasonographic pathology. J Rheumatol. 2005;32(12):2485-7.; Skorpen CG, Hoeltzenbein M, Tincani A, Fischer-Betz R, Elefant E, Chambers C, et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Annals of the rheumatic diseases. 2016;75(5):795-810.; Flint J, Panchal S, Hurrell A, Venne Mvd, Gayed M, Schreiber K, et al. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part II: analgesics and other drugs used in rheumatology practice. Rheumatology. 2016;55(9):1698-702.; Østensen M, Khamashta M, Lockshin M, Parke A, Brucato A, Carp H, et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis research & therapy. 2006;8(3):209.; Panchal S, Khare M, Moorthy A, Samanta A. Catch me if you can: a national survey of rheumatologists and obstetricians on the use of DMARDs during pregnancy. Rheumatol Int. 2013;33(2):347-53.; Rau R, Herborn G. A modified version of Larsen´s scoring method to assess radiologic changes in rheumatoid arthritis. J Rheumatol. 1995;22:1976-82.; Backhaus M, Burmester G, Gerber T, Grassi W, Machold K, Swen W, et al. Guidelines for musculoskeletal ultrasound in rheumatology. Ann Rheum Dis. 2001;60:641–9.; Duffy DM. Novel contraceptive targets to inhibit ovulation: the prostaglandin E2 pathway. Hum Reprod Update. 2015;21(5):652–70.; Dathe K, Fietz AK, Pritchard LW, Padberg S, Hultzsch S, Meixner K, et al. No evidence of adverse pregnancy outcome after exposure to ibuprofen in the first trimester - evaluation of the national Embryotox cohort. Reprod Toxicol. 2018;79:32–8.; Nakhai-Pour HR, Broy P, Sheehy O, Berard A. Use of nonaspirin nonsteroidal anti-inflammatory drugs during pregnancy and the risk of spontaneous abortion. CMAJ. 2011;183(15):1713–20.; Viktil KK, Engeland A, Furu K. Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150, 000 pregnant women and expectant fathers. Scand J Rheumatol. 2012;41(3):196-201.; Palmsten K, Hernandez-Diaz S, Kuriya B, Solomon DH, Setoguchi S. Use of disease-modifying antirheumatic drugs during pregnancy and risk of preeclampsia. Arthritis Care Res. 2012;64(11):1730-8.; Bermas BL. Non-steroidal anti inflammatory drugs, glucocorticoids and disease modifying anti-rheumatic drugs for the management of rheumatoid arthritis before and during pregnancy. Current opinion in rheumatology. 2014;26(3):334-40.; Krause ML, Makol A. Management of rheumatoid arthritis during pregnancy: challenges and solutions. Open access rheumatology: research and reviews. 2016;8:23.; Diav-Citrin O, Blyakhman S, Shechtman S, Ornoy A. Pregnancy outcome following in utero exposure to hydroxychloroquine: a prospective comparative observational study. Reproductive Toxicology. 2013;39:58-62.; Sperber K, Hom C, Chao CP, Shapiro D, Ash J. Systematic review of hydroxychloroquine use in pregnant patients with autoimmune diseases. Pediatric Rheumatology. 2009;7(1):9.; Norgard B, Pedersen L, Christensen LA, Sorensen HT. Therapeutic drug use in women with Crohn’s disease and birth outcomes: a Danish nationwide cohort study. Am J Gastroenterol. 2007;102(7):1406-13.; AAP. Pediatrics. Transfer of drugs and other chemicals into human milk. 2001;108(3):776–89.; Kemp MW, Newnham JP, Challis JG, Jobe AH, Stock SJ. The clinical use of corticosteroids in pregnancy. Hum Reprod Update. 2016;22(2):240–59.; Noviani M, Wasserman S, Clowse ME. Breastfeeding in mothers with systemic lupus erythematosus. Lupus. 2016;25(9):973-9.; Weber-Schoendorfer C, Beck E, Tissen-Diabaté T, Schaefer C. Leflunomide–a human teratogen? A still not answered question. An evaluation of the German Embryotox pharmacovigilance database. Reproductive Toxicology. 2017;71:101-7.; Chambers CD, Johnson DL, Robinson LK, Braddock SR, Xu R, Lopez‐Jimenez J, et al. Birth outcomes in women who have taken leflunomide during pregnancy. Arthritis & Rheumatism. 2010;62(5):1494-503.; Weber‐Schoendorfer C, Chambers C, Wacker E, Beghin D, Bernard N, Centers NoFP, et al. Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study. Arthritis & Rheumatology. 2014;66(5):1101-10.; Weber Schoendorfer C, Chambers C, Wacker E, Beghin D, Bernard N, Centers NoFP, et al. Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study. Arthritis & Rheumatology. 2014;66(5):1101-10.; Mozaffari S, Abdolghaffari A, Nikfar S, Abdollahi M. Pregnancy outcomes in women with inflammatory bowel disease following exposure to thiopurines and antitumor necrosis factor drugs: a systematic review with meta-analysis. Human & experimental toxicology. 2015;34(5):445-59.; Rein P, Mueller RB. Treatment with biologicals in rheumatoid arthritis: an overview. Rheumatology and therapy. 2017;4(2):247-61.; Siebert S, Tsoukas A, Robertson J, McInnes I. Cytokines as therapeutic targets in rheumatoid arthritis and other inflammatory diseases. Pharmacological reviews. 2015;67(2):280-309.; Hodge J, Kawabata T, Krishnaswami S, Clark J, Telliez J, Dowty M, et al. The mechanism of action of tofacitinib-an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis. Clin Exp Rheumatol. 2016;34(2):318-28.; Lai J-H, Ling XC, Ho L-J. Useful message in choosing optimal biological agents for patients with autoimmune arthritis. Biochemical pharmacology. 2019;165:99-111.; Lau CS, Chia F, Dans L, Harrison A, Hsieh TY, Jain R, et al. 2018 update of the APLAR recommendations for treatment of rheumatoid arthritis. International journal of rheumatic diseases. 2019;22(3):357-75.; Tsao NW, Lynd LD, Sadatsafavi M, Hanley G, De Vera MA. Patterns of Biologics Utilization and Discontinuation Before and During Pregnancy in Women With Autoimmune Diseases: A Population Based Cohort Study. Arthritis care & research. 2018;70(7):979-86.; Clowse ME. The use of anti-TNFα medications for rheumatologic disease in pregnancy. International journal of women‘s health. 2010;2:199.; Luu M, Benzenine E, Doret M, Michiels C, Barkun A, Degand T, et al. Continuous anti-tnfα use throughout pregnancy: possible complications for the mother but not for the fetus. A retrospective cohort on the French National Health Insurance Database (EVASION). The American journal of gastroenterology. 2018;113(11):1669.; Palmeira P, Quinello C, Silveira-Lessa AL, Zago CA, Carneiro-Sampaio M. IgG placental transfer in healthy and pathological pregnancies. Clinical and Developmental Immunology. 2011;2012.; Lichtenstein GR, Feagan BG, Mahadevan U, Salzberg BA, Langholff W, Morgan GJ, et al. Pregnancy outcomes reported during the 13-Year TREAT registry: a descriptive report. The American journal of gastroenterology. 2018;113(11):1678.; Matro R, Martin CF, Wolf D, Shah SA, Mahadevan U. Exposure concentrations of infants breastfed by women receiving biologic therapies for inflammatory bowel diseases and effects of breastfeeding on infections and development. Gastroenterology. 2018;155(3):696-704.; Chakravarty EF, Murray ER, Kelman A, Farmer P. Pregnancy outcomes after maternal exposure to rituximab. Blood. 2011;117(5):1499-506.; Mandal PK, Dolai TK, Bagchi B, Ghosh MK, Bose S, Bhattacharyya M. B cell suppression in newborn following treatment of pregnant diffuse large B-cell lymphoma patient with rituximab containing regimen. The Indian Journal of Pediatrics. 2014;81(10):1092-4.; Rubbert-Roth A, Goupille PM, Moosavi S, Hou A. First experiences with pregnancies in RA patients (pts) receiving tocilizumab (TCZ) therapy. Arthritis Rheum. 2010;62(Suppl 10):384.; Gerosa M, Argolini LM, Artusi C, Chighizola CB. The use of biologics and small molecules in pregnant patients with rheumatic diseases. Expert review of clinical pharmacology. 2018;11(10):987-98.; Clowse ME, Forger F, Hwang C, Thorp J, Dolhain RJ, Tubergen Av, et al. Minimal to no transfer of certolizumab pegol into breast milk: results from CRADLE, a prospective, postmarketing, multicenter, pharmacokinetic study. Ann Rheum Dis. 2017;76(11):1890–6.; Andreoli L, Bertsias G, Agmon-Levin N, Brown S, Cervera R, Costedoat-Chalumeau N, et al. EULAR recommendations for women‘s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Annals of the rheumatic diseases. 2017;76(3):476-85.; Shimada H, Kameda T, Kanenishi K, Miyatake N, Nakashima S, Wakiya R, et al. Effect of biologic disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis who hope to become mothers. Clinical rheumatology. 2019:1-6.; Tsao NW, Sayre EC, Hanley G, Sadatsafavi M, Lynd LD, Marra CA, et al. Risk of preterm delivery and small-for-gestational-age births in women with autoimmune disease using biologics before or during pregnancy: a population-based cohort study. Annals of the rheumatic diseases. 2018;77(6):869-74.; van den Brandt S, Zbinden A, Baeten D, Villiger PM, Østensen M, Förger F. Risk factors for flare and treatment of disease flares during pregnancy in rheumatoid arthritis and axial spondyloarthritis patients. Arthritis research & therapy. 2017;19(1):64.; http://www.revista.spr.org.py/index.php/spr/article/view/119

الاتاحة: http://www.revista.spr.org.py/index.php/spr/article/view/119
https://doi.org/10.18004/rpr/2020.06.01.36-47

المؤلفون: Aldo Ojeda, Elías Rojas, Rodrigo Acosta, Mitha Maidana, Julio Ramírez, Margarita Duarte

المصدر: Paraguayan Journal of Rheumatology; Vol. 6 Núm. 2 (2020): Julio-Diciembre; 70-78 ; Revista Paraguaya de Reumatología; Vol. 6 Núm. 2 (2020): Julio-Diciembre; 70-78 ; 2413-4341 ; 2413-709X

وصف الملف: application/pdf

Relation: http://www.revista.spr.org.py/index.php/spr/article/view/127/220; Bakland G, Nossent HC. Epidemiology of spondyloarthritis: A re view. Curr Rheumatol Rep. 2013;15(9):1–7.; Terslev L, Naredo E, Iagnocco A, Balint PV, Wakefield RJ, Aegerter P, et al. Outcome Measures in Rheumatology Ultrasound Task Force. Defining enthesitis in spondyloarthritis by ultrasound: results of a Delphi process and of a reliability reading exercise. Arthritis Care Res (Hoboken). 2014 May;66(5):741-8. doi:10.1002/acr.22191.; Mata Arnaiz MC, de Miguel Mendieta E. Utilidad de la ecografía en la evaluación de las entesis periféricas en las espondiloartritis. Reumatol Clin. 2014;10(2):113–9.; Zhang H, Liang J, Qiu J, Wang F, Sun L. Ultrasonographic evalua- tion of enthesitis in patients with ankylosing spondylitis. J Biomed Res. 2017;31(2):162–9.; Aguila Maldonado R, Ruta S, Valuntas ML, García M. Ultrasono- graphy assessment of heel entheses in patients with spondylo- arthritis: a comparative study with magnetic resonance imaging and conventional radiography. Clin Rheumatol. 2017;36(8):1811–7.; Groves C, Chandramohan M, Chew NS, Aslam T, Helliwell PS. Clinical Examination, Ultrasound and MRI Imaging of The Painful Elbow in Psoriatic Arthritis and Rheumatoid Arthritis: Which is Better, Ultrasound or MR, for Imaging Enthesitis? Rheumatol Ther. 2017;4(1):71–84.; Eder L, Barzilai M, Peled N, Gladman DD, Zisman D. The use of ultrasound for the assessment of enthesitis in patients with spondy- loarthritis. Clin Radiol [Internet]. 2013;68(3):219–23. Available from: http://dx.doi.org/10.1016/j.crad.2012.07.018; Sakellariou G, Iagnocco A, Delle Sedie A, Riente L, Filippucci E, Montecucco C. Ultrasonographic evaluation of entheses in patients with spondyloarthritis: A systematic literature review. Clin Exp Rheu- matol. 2014;32(6):969–78.; Filippucci E, Zehra Aydin S, Karadag O, Salaffi F, Gutierrez M, Direskeneli H, et al. Reliability of high-resolution ultrasonography in the assessment of Achilles tendon enthesopathy in seronegative spondyloarthropathies. Ann Rheum Dis. 2009;68(12):1850–5.; Poulain C, D’Agostino MA, Thibault S, Daures JP, Ferkal S, Le Corvoisier P, et al. Can power Doppler ultrasound of the entheses help in classifying recent axial spondyloarthritis? Data from the DESIR cohort. RMD Open. 2018;4(2):1–9.; Balint P V., Kane D, Wilson H, McInnes IB, Sturrock RD. Ultrasono- graphy of entheseal insertions in the lower limb in spondyloarthro- pathy. Ann Rheum Dis. 2002;61(10):905–10.; D’Agostino MA, Said-Nahal R, Hacquard-Bouder C, Brasseur JL, Dougados M, Breban M. Assessment of peripheral enthesitis in the spondylarthropathies by ultrasonography combined with power Doppler: A cross-sectional study. Arthritis Rheum. 2003;48(2): 523–33.; De Miguel E, Cobo T, Muñoz-Femández S, Naredo E, Usón J, Acebes JC, et al. Validity of enthesis ultrasound assessment in spondyloarthropathy. Ann Rheum Dis. 2009;68(2):169–74.; Macchioni P, Salvarani C, Possemato N, Gutierrez M, Grassi W, Gasparini S, et al. Ultrasonographic and Clinical Assessment of Peripheral Enthesitis in Patients with Psoriatic Arthritis, Psoriasis, and Fibromyalgia Syndrome: The ULISSE Study. J Rheumatol. 2019;46(8):904–11.; Kristensen S, Christensen JH, Schmidt EB, Olesen JL, Johansen MB, Arvesen KB, et al. Assessment of enthesitis in patients with psoriatic arthritis using clinical examination and ultrasound. Muscles Ligaments Tendons J. 2016;6(2):241–7.; Ruyssen-Witrand A, Jamard B, Cantagrel A, Nigon D, Loeuille D, Degboe Y, et al. Relationships between ultrasound enthesitis, disease activity and axial radiographic structural changes in patients with early spondyloarthritis: Data from DESIR cohort. RMD Open. 2017;3(2):1–8.; Spadaro A, Iagnocco A, Perrotta FM, Modesti M, Scarno A, Valesini G. Clinical and ultrasonography assessment of peripheral enthesitis in ankylosing spondylitis. Rheumatology (Oxford). 2011; 50(11):2080–6.; De Filippis LG, Caliri A, Lo Gullo R, Bartolone S, Miceli G, Cannavò SP, et al. Ultrasonography in the early diagnosis of psoriasis-asso- ciated enthesopathy. Int J Tissue React. 2005;27(4):159–62.; Galluzzo E, Lischi DM, Taglione E, Lombardini F, Pasero G, Perri G, et al. Sonographic analysis of the ankle in patients with psoriatic arthritis. Scand J Rheumatol. 2000;29(1):52–5.; Michelsen B, Diamantopoulos AP, Soldal DM, Hammer HB, Kavanaugh A, Haugeberg G. Achilles enthesitis defined by ultra- sound is not associated with clinical enthesitis in patients with psoriatic arthritis. RMD Open. 2017;3(2):1–5.; Bandinelli F, Prignano F, Bonciani D, Bartoli F, Collaku L, Candelieri A, et al. Ultrasound detects occult entheseal involvement in early psoriatic arthritis independently of clinical features and psoriasis severity. Clin ExpRheumatol. 2013;31(2):0219–24.; Hamdi W, Bouaziz Chelli M, Ghannouchi MM, Hawel M, Ladeb MF, Kchir MM. Performance of ultrasounds compared with radiographs to detect chronic enthesitis signs in patients with ankylosing spondylitis. Rheumatol Int. 2013;33(2):497–9.; De Miguel E, Falcao S, Castillo C, Plasencia C, García M, Branco JC, et al. Enthesis erosion in spondyloarthritis is not a persistent structural lesion. Ann Rheum Dis. 2011;70(11):2008–10.; Lanfranchi MA, Leluc O, Tavano A, Wormser C, Morange S, Chagnaud C, et al. Are ultrasound findings similar in patients with axial spondyloarthritis and in athlete entheses? J Rheumatol. 2017;44(5):609–12.; Eder L, Jayakar J TA. Ultrasonographic entheseal abnormalities among patients with psoriatic arthritis, psoriasis alone and healthy individuals and their correlation with disease-related variables. Arthritis Rheum. 2012;64:S582.; De Miguel E, Muñoz-Fernández S, Castillo C, Cobo-Ibáñez T, Martín-Mola E. Diagnostic accuracy of enthesis ultrasound in the diagnosis of early spondyloarthritis. Ann Rheum Dis. 2011;70(3):434–9.; http://www.revista.spr.org.py/index.php/spr/article/view/127

الاتاحة: http://www.revista.spr.org.py/index.php/spr/article/view/127
https://doi.org/10.18004/rpr/2020.06.02.70

المؤلفون: Marcos Aurelio Vázquez, Elías Rojas, Jonathan Losanto, Karin Bauman, María Eugenia Acosta, Gabriela Avila, Marcia Melo, María Margarita Duarte, Isabel Acosta Colman

المصدر: Memorias del Instituto de Investigaciones en Ciencias de la Salud, Vol 17, Iss 1, Pp 69-74 (2019)

مصطلحات موضوعية: lupus eritematoso sistémico, registro lupus-py, características clínico-epidemiológicas, Medicine (General), R5-920

Relation: https://revistascientificas.una.py/index.php/RIIC/article/view/2543; https://doaj.org/toc/1817-4620; https://doaj.org/toc/1812-9528; https://doaj.org/article/d1986c28e60e4877af83ae3d8fbc7645

الاتاحة: https://doaj.org/article/d1986c28e60e4877af83ae3d8fbc7645

المؤلفون: Aldo Ojeda, Yanira Yinde, Nelly Colmán, Elías Rojas, Karin Baumann

المصدر: Paraguayan Journal of Rheumatology; Vol. 5 Núm. 1 (2019): Enero-Junio; 20-26 ; Revista Paraguaya de Reumatología; Vol. 5 Núm. 1 (2019): Enero-Junio; 20-26 ; 2413-4341 ; 2413-709X

وصف الملف: application/pdf

Relation: http://www.revista.spr.org.py/index.php/spr/article/view/100/198; González-Gay M, Vazquez-Rodriguez T, López-Diaz, Miranda-Filloy J, Gonzalez-Juanatey C, Epidemiology of GiantCell Arteritis and Polymyalgia Rheumatica. Arthritis & Rheumatism (ArthritisCare&Research). 2009;61(10):1454–1461.; Kesten F, Aschwanden M, Gubser P, Glatz K , Daikeler T. Giant cell arteriitis – a changing entity Swiss Med Wkly. 2011;141:w13272 (art. on line).; Salvarani C, Cantini F, Hunder GG, Polymyalgia rheumatica and giant cell arteritis. Lancet. 2008;372(9634): 234-245.; Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. ArthritisRheum. 2013;65(1):1-11.; Ness T, Bley TA, Schmidt WA, Lamprecht P: The diagnosis and treatment of giant cell arteritis. DtschArzteblInt. 2013;110(21):376–86.; Walvick MD, Walvick MP. Giant cell arteritis: laboratory predictors of a positive temporal artery biopsy. Ophthalmology. 2011;118(6):1201-4.; Rieck KL, Kermani TA, Thomsen KM, Harmsen WS, Karban MJ, Warrington KJ. Evaluation for clinical predictors of positive temporal artery biopsy in giant cell arteritis. J Oral MaxillofacSurg. 2011;69(1):36-40.; Mari B, Monteagudo M. Arterial biopsy in giant cell arteries and polymyalgia rheumatica. Eur J InternMed. 2010;21(6):572-3.; Gonzalez-Gay MA, Vazquez-Rodriguez TR, Lopez-Diaz MJ, Miranda Filloy JA, Gonzalez-Juanatey C, Martin J, Llorca J. Epidemiology of giantcell arteritis and polymyalgiarheumatica. ArthritisRheum. 2009;61(10):1454-61.; Mohammad AJ, Nilsson JA, Jacobsson LT, Merkel PA, Turesson C. Incidence and mortality rates of biopsyproven giant cell arteritis in southern Sweden. Ann RheumDispublished. 2014.; Vaith P, Warnatz K. Clinical and serological findings of giant-cell arteritis. Z Rheumatol. 2009;68:124–31.; Blockmans D The use of (18F) fluoro-deoxyglucose positron emission tomography in the assessment of large vessel vasculitis. ClinExpRheumatol. 2009;21:15–22.; Robson JC, Kiran A, Maskell J, Hutchings A, Arden N The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UKAnn Rheum Dis. Published online 2013.; Maksimowicz-McKinnonK,ClarkTM,HoffmanGS:Takayasuarteritis and giant cell arteritis: a spectrum within the same disease? Medicine 2009;88: 221–6.; Kermani TA, Warrington KJ, Crowson CS, Ytterberg SR, Hunder GG, Gabriel SE, Matteson EL: Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis. Ann RheumDis. 2012.; Nesher G. The diagnosis and classification of giant cell arteritis. J Autoinmmun. 2014.; Figus M, Talarico R, Posarelli C, d‘Ascanio A, Elefante E, Bombardieri S. Ocular involvement in giantcell arteritis. ClinExp Rheumatol. 2013;3(1 Suppl 75):S96.; Charlton R. Optimal management of giant cell arteritis and polymyalgia rheumatica. Therapeutics and Clinical Risk Management. 2012:(8)173–179.; Van Hecke O Polymyalgia rheumatica -- diagnosis and management. AustFam Physician. 2011;40(5):303-6.; Mackie SL, Pease CT Diagnosis and manangement of giant cell arteritis and polymyalgia rheumatica: challenges, controversies and practical tips. PostgradMed J. 2013;89(1051):284-92.; Barraclough K, Mallen CD, Helliwell T, Hider SL, Dasgupta B. Di agnosis and management of giant cell arteritis. Br J Gen Pract. 2012;62(599):329-30.; De AraújoMedeiros D, De Miguel E. A ecografiadopplercomcor no diagnóstico da arterite das células gigantes. Acta reumatolport. 2009;34:183-189.; Villa I, Bilbao M, Martinez-Taboada v. Avances en el diagnóstico de las vasculitis de vasos de gran calibre: identificación de biomarca- dores y estudios de imagen. ReumatolClin. 2011;7(S3):S22–S27; Pacheco M, Mínguez M, Martínez A, Bernabeu M. Diagnóstico precoz de las vasculitis de grandes vasos. utilidad de la tomografía por emisión de positrones con la tomografía axial computarizada. ReumatolClin. 2013;9(1):65–68.; Breuer G, Nesher R, Reinus K, Nesher G Association between Histological Features in temporal artery Biopsies and clinical Features of Patients with giant cell arteritis isr Med Assoc J. 2013 Jun;15(6):271-4; Smetana GW, Shmerling RH. Does this patient have temporal arteritis? JAMA 2002;287:92-101.; Saedon H, Saedon M, Goodyear S, Papettas T, Marshall C. Temporal artery biopsy for giant cell arteritis: retrospective audit. J R SocMedShRep. 2012;3:73.; Dasgupta B, Borg FA, Hassan N, Alexander L, BSR and BHPR guidelines for the management of giant cell arteritis. Rheumatology (Oxford). 2010;49(8):1594-7; MahrAD,JoverJA,SpieraRF,etal.:Adjunctive methotrexate for treat- ment of giant cell arteritis: an individual patient data meta-analysis. ArthritisRheum. 2007; 56:2789–97.; Diamantopoulos AP, Hetland H, Myklebust G. Leflunomide as acorticosteroid-sparing agent in giantcell arteritisand polymyalgiar- heumatica: a case series. Biomed Res int. Epub 2013.; Hoffman GS, Cid MC, RendtZagar KE, Merkel A,Infliximab forma maintenance of glucocorticosteroid induced remission of giant cell arteritis: a randomized trial. Ann internMed. 2007;146(9):621-30.; Karassa FB, Matsagas Mi, Schmidt WA, Ioannidis JPA: Meta- analysis: test performance of ultrasonography for giant-cell arteritis. Ann internMed. 2005;142:359-369.; Villiger PM, Adler S, Kuchen S, et al. Tocilizumabforinduction and maintenance of remission in giantcell arteritis: A phase 2, rando- mised, double-blind, placebo-controlled trial. Lancet. 2016;387:1921.; Stone JH, Tuckwell K, Dimonaco S, et al. Trial of tocilizumab in giant-cell arteritis. N Engl J Med. 2017;377:317.; Unizony S, Arias-urdaneta L, Miloslavsky E, et al. Tocilizumabfort- hetreatment of large-vessel vasculitis (giantcell arteritis, Takaya su arteritis) and polymyalgiarheumatica. ArthritisCare Res (Hoboken) 2012;64:1720.; Pfeil A, Oelzner P, Hellmann P. The Treatment of Giant Cell Arteritis in Different Clinical Settings. Front immunol. 2019;9:3129.; http://www.revista.spr.org.py/index.php/spr/article/view/100

الاتاحة: http://www.revista.spr.org.py/index.php/spr/article/view/100
https://doi.org/10.18004/rpr/2019.05.01.20-26

المؤلفون: Aldo Ojeda, Yanira Yinde, Nelly Colmán, Elías Rojas, Karin Baumann

المصدر: Revista Paraguaya de Reumatología, Vol 5, Iss 1, Pp 20-26 (2019)

مصطلحات موضوعية: arteritis de células gigantes, diagnóstico, tratamiento, Internal medicine, RC31-1245, Diseases of the musculoskeletal system, RC925-935

Relation: http://www.revista.spr.org.py/index.php/spr/article/view/100; https://doaj.org/toc/2413-709X; https://doaj.org/toc/2413-4341; https://doaj.org/article/48a3fb8ea7d2488ab80dd0a0f9aab03e

الاتاحة: https://doaj.org/article/48a3fb8ea7d2488ab80dd0a0f9aab03e

المؤلفون: Paulus, Jefrey Elias Rojas

Thesis Advisors: Rezende, Maria Lucia Rubo de

مصطلحات موضوعية: Acido citrico, Bone graft, Bone morfogenetic protein, Citric acid, Enxerto ósseo, Periodontia, Periodontics, Proteinas osseas morfogeneticas

وصف الملف: application/pdf

الاتاحة: http://www.teses.usp.br/teses/disponiveis/25/25146/tde-13092016-100000/

المؤلفون: Lourdes Román, Susan Riquelme, Jhonatan Losanto, Elías Rojas, María Eugenia Acosta, María Teresa Martínez, Margarita Duarte, Isabel Acosta Colman

المصدر: Paraguayan Journal of Rheumatology; Vol. 2 Núm. 1 (2016): Enero-Junio; 24-28 ; Revista Paraguaya de Reumatología; Vol. 2 Núm. 1 (2016): Enero-Junio; 24-28 ; 2413-4341 ; 2413-709X

وصف الملف: application/pdf; text/html

Relation: http://www.revista.spr.org.py/index.php/spr/article/view/29/46; http://www.revista.spr.org.py/index.php/spr/article/view/29/102; Mok CC, Lau CS. Pathogenesis of systemic lupus erythematosus. J Clin Pathol. 2003;56:481-490.; D’ Crux DP, Khamashta MA, Hughes GR. Systemic lupuserythematosus. Lancet. 2007;369(9561):587-96.; Li PH, Hing W, Wong S, et al. Relationship between autoantibody clustering and clinical subsets in SLE: Cluster and association analyses in Hong Kong Chinese. Rheumatology (Oxford). 2013; 52:337-345.; Uva L, Miguel D, Pinheiro C, Freitas JP, Marques Gomes M, Filipe P. Cutaneous manifestations of systemic lupus erythematosus. Autoimmune Dis. 2012;2012:834291.; Holick MF (2004) Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 80:1678S-1688S; Vinh qu c Lu‘o‘ngK, Nguy n LT (2013) The beneficial role of vitamin D in obesity: possible genetic and cell signaling mechanisms. Nutr. J12:89; HolickMF (2007) Vitamin D deficiency. N Engl JMed. 357:266-281; GrantWB (2006) Epidemiology of disease risks in relation to vitamin D insufficiency. Prog Biophys Mol Biol. 92:65-79.; Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C (2010) Vitamin D: modulator of the immune system. Curr Opin Pharmacol. 10:482-496.; Arnson Y, Amital H, Shoenfeld Y (2007) Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis. 66:1137-1142.; Adorini L, Penna G (2008) Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol. 4:404-412.; Daniel C, Sartory NA, Zahn N, Radeke HH, Stein JM(2008) Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther. 324:23-33.; Lemire JM, Ince A, TakashimaM(1992) 1,25-Dihydroxyvitamin D3attenuates the expression of experimental murine lupus of MRL/l mice. Autoimmunity. 12:143-148.; O‘Regan S, Chesney RW, Hamstra A, Eisman JA, O‘Gorman AM,Deluca HF (1979) Reduced serum 1,25-(OH)2 vitamin D3 levels in prednisone-treated adolescents with systemic lupus erythematosus. Acta Paediatr Scand. 68:109-111.; Sakthiswary R, Raymond AA (2013) The clinical significance of vitamin D in systemic lupus erythematosus: a systematic review. PLoS One. 8:e55275.; Kamen DL, Aranow C (2008) The link between vitamin D deficiency and systemic lupus erythematosus. Curr Rheumatol Rep. 10:273-280.; Bonakdar ZS, Jahanshahifar L, Jahanshahifar F, Gholamrezaei A (2011) Vitamin D deficiency and its association with disease activity in new cases of systemic lupus erythematosus. Lupus. 20:1155-1160.; Oneil S, Cervera R. Sistemyc Lupus erythematosus. Best Prac Res Clin Rheumatol. 2010;24(6):841-55.; Souto, M. I. D., Coelho, A., Guo, C., Mendonça, L. M. C., Argolo, S., Papi, J. A. S., & Farias, M. L. F. (2011). Vitamin D insufficiency in Brazilian patients with SLE: prevalence, associated factors, and relationship with activity. Lupus. 20(10),1019-1026.; Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM et al (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 96:53-58.; Monticielo OA, Teixeira TM, Chies JA, Brenol JC, Xavier RM (2012) Vitamin D and polymorphisms of VDR gene in patients with systemic lupus erythematosus. Clin Rheumatol. 31:1411-1421.; Costenbader KH, Feskanich D, Holmes M, Karlson EW, Benito- Garcia E (2008) Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women. Ann Rheum Dis. 67:530-535.; http://www.revista.spr.org.py/index.php/spr/article/view/29

الاتاحة: http://www.revista.spr.org.py/index.php/spr/article/view/29

المؤلفون: Lourdes Román, Elías Rojas, Marcos Aurelio Vázquez, María Eugenia Acosta, Marcia Melo Martínez, Margarita Duarte

المصدر: Paraguayan Journal of Rheumatology; Vol. 2 Núm. 1 (2016): Enero-Junio; 13-17 ; Revista Paraguaya de Reumatología; Vol. 2 Núm. 1 (2016): Enero-Junio; 13-17 ; 2413-4341 ; 2413-709X

وصف الملف: application/pdf; text/html

Relation: http://www.revista.spr.org.py/index.php/spr/article/view/27/44; http://www.revista.spr.org.py/index.php/spr/article/view/27/100; Lemusa, N, Parradoa R, Quintana G. Calidad de vida en el sistema de salud. Rev. Colomb. Reumatol. 2014;21(1):1-3.; Vilagut G, Ferrer M, Rajmil, L, Rebollo, P, Permanyer-Miralda G , Quintana JM, et al. El cuestionario de salud SF-36 español: una década de experiencia y nuevos desarrollos. Gaceta sanitaria. 2005;19(2):135-150.; Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29(2):288-91.; Fortin, PR, Abrahamowicz M, Neville C, Du Berger R, Fraenkel L, C larke AE, et al. Impact of disease activity and cumulative damage on the health of lupus patients. Lupus.1998;7(2):101-7.; Stoll T, Gordon C, Seifert B, Richardson K, Malik J, Bacon PA,et al. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus. J Rheu. matol. 1997;24(8):1608-14.; Dobkin PL, da Costa D, Dritsa M, Fortin PR, Senécal J-L, Goulet J-R, et al. Quality of life in systemic lupus erythematosus patients during more and less active disease states: differential contributors to mental and physical health. Arthritis Care Res. 1999;12:401-10.; Alarcón GS, Roseman JM, Bartolucci AA, Friedman AW, Moulds JM, Goel N, et al. Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course. Arthritis Rheum. 1998;41:1173-80.; Mok, C. C., Ho, L. Y., Cheung, M. Y., Yu, K. L., To, C. H. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2‐year prospective study. Scand J R heumatol. 2009;38(2):121-127.; González-Rodríguez V., Peralta-Ramírez M. I., Navarrete-Navarrete N., Callejas-Rubio, J. L., Ruiz, A. M. S., Khamashta, M. Adaptación y validación de la versión española de una medida específica de la calidad de vida en los pacientes con lupus eritematoso sistémico: el Lupus Quality of Life. Med Clín. 2010;134(1),13-16.; Pedroso B, Pilatti LA, Gutierrez GL, Santos CB, Picinin CT. Qualidade de vida: uma ferramenta para o cálculo dosescores e estatística descritiva do WHOQOL-100. Validacão dasintaxe unificada para o cálculo dos escores dos instrumentosWHOQOL. Conexões: Revista da Faculdade de Educacão Físicada Unicamp. 2011;9(1):130-56.; Zheng Y, Ye DQ, Pan HF, Li WX, Li LH, Li J et al. Influence of social support on health-related quality of life in patients with systemic lupus erythematosus. Clin Rheumatol. 2009;28(3):265-9.; Khanna S, Pal H, Pandey RM, Handa R. The relationship between disease activity and quality of life in systemic lupus erythematosus. Rheumatology (Oxford). 2004;43(12):1536-40.; Araujo AD, Traverso-Yepez MA. Expressões e sentidos do lúpus eritematoso sistêmico (LES). Estud psicol (Natal). 2007;12(2): 119-127.; Vilagut, G., Ferrer, M., Rajmil, L., Rebollo, P., Permanyer-Miralda, G ., Quintana, et al. El cuestionario de salud SF-36 español: una década de experiencia y nuevos desarrollos. Gac Sanit. 2005; 19(2),135-150.; Vilagut, G., Valderas, J. M., Ferrer, M., Garin, O., López-Gacía, Alonso, J. Interpretación de los cuestionarios de salud SF-36 y SF-12 en España: componentes físico y mental. Med Clín. 2008; 130(19),726-735.; Ariza, K., Isaza, P., Gaviria, A. M., Quiceno, J. M., Vinaccia, S., Alvarán, L., et al. Calidad de vida relacionada con la salud, factores psicológicos y fisiopatológicos en pacientes con diagnóstico de Lupus Eritematoso Sistémico-LES. Ter Psicol. 2010.28(1),27-36.; Fernández, M., Calvo‐Alén, J., Alarcón, G. S., Roseman, J. M., Bastian, H. M., Fessler, B. J., et al (2005). Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXI. Disease activity, damage accrual, and vascular events in pre‐and postmenopausal women. Arthritis & Rheumatism. 2005; 52(6),1655-1664.; http://www.revista.spr.org.py/index.php/spr/article/view/27

الاتاحة: http://www.revista.spr.org.py/index.php/spr/article/view/27

المؤلفون: Lourdes Román, Elías Rojas, Marcos Aurelio Vázquez, María Eugenia Acosta, Marcia Melo Martínez, Margarita Duarte

المصدر: Revista Paraguaya de Reumatología, Vol 2, Iss 1, Pp 13-17 (2016)

مصطلحات موضوعية: calidad de vida, sledai, haq, sf36, Internal medicine, RC31-1245, Diseases of the musculoskeletal system, RC925-935

Relation: http://www.revista.spr.org.py/index.php/spr/article/view/27; https://doaj.org/toc/2413-709X; https://doaj.org/toc/2413-4341; https://doaj.org/article/f28ce88ee77c4aa2846b77fd65928041

الاتاحة: https://doaj.org/article/f28ce88ee77c4aa2846b77fd65928041

المؤلفون: Lourdes Román, Susan Riquelme, Jhonatan Losanto, Elías Rojas, María Eugenia Acosta, María Teresa Martínez, Margarita Duarte, Isabel Acosta Colman

المصدر: Revista Paraguaya de Reumatología, Vol 2, Iss 1, Pp 24-28 (2016)

مصطلحات موضوعية: lupus eritematoso sistémico, vitamina d, Internal medicine, RC31-1245, Diseases of the musculoskeletal system, RC925-935

Relation: http://www.revista.spr.org.py/index.php/spr/article/view/29; https://doaj.org/toc/2413-709X; https://doaj.org/toc/2413-4341; https://doaj.org/article/1d9a6ebd10464eeaa32cfee8de0f1fe8

الاتاحة: https://doaj.org/article/1d9a6ebd10464eeaa32cfee8de0f1fe8

المؤلفون: Esther Guadalupe Carmona Vega, Juan Elías Rojas Hernández

المصدر: info:eu-repo/semantics/altIdentifier/eissn/ ; NovaRua; Vol. 3 Núm. 5 (2012) ; 2007-4042 ; 10.20983/novarua.2012.5

مصطلحات موضوعية: edad, jubilación, pensión, beneficios, planes de aseguramiento

Relation: http://erevistas.uacj.mx/ojs/index.php/NovaRua/article/view/30

الاتاحة: http://erevistas.uacj.mx/ojs/index.php/NovaRua/article/view/30

المؤلفون: Elias Rojas, Betzabeth Yomira, Sairitupa Altamirano, Rossy Claydi

المساهمون: Tineo Tueros, Mirella Pamela

مصطلحات موضوعية: Propóleo, Enterococcus faecalis, Endodoncia, Antibióticos, Conducto radicular, https://purl.org/pe-repo/ocde/ford#3.02.14

وصف الملف: application/pdf

Relation: https://repositorio.utea.edu.pe/handle/utea/301

الاتاحة: https://repositorio.utea.edu.pe/handle/utea/301

المؤلفون: Deyvid Tamara Roncancio, Elías Rojas Martínez, Luis Quintero López, Frank Lascarro Navarro, Dino Carmelo Manco Jaraba

المصدر: Tecnura, Vol 28, Iss 79, Pp 123-139 (2024)

مصطلحات موضوعية: formación la quinta, geoquímica icp-ms, serranía del perijá, volcanismo, Technology, Engineering (General). Civil engineering (General), TA1-2040

وصف الملف: electronic resource

Relation: https://revistas.udistrital.edu.co/index.php/Tecnura/article/view/20824; https://doaj.org/toc/0123-921X; https://doaj.org/toc/2248-7638

URL الوصول: https://doaj.org/article/f05820cd78764c48a149e7aec67c14d9